News & Perspective

Jan 30, 2013

Jan 30, 2013

Study finds post-H1N1-vaccination rise in narcolepsy in 3 nations

(CIDRAP News) – A large study of narcolepsy background rates in six European countries before and after 2009 H1N1 pandemic vaccine campaigns confirmed increases in Finland and Sweden—the two countries that first reported the problem—but also detected a rise in Denmark.

Sep 21, 2012

Sep 21, 2012

French study finds narcolepsy link to H1N1 vaccine in adults

(CIDRAP News) – French researchers have found a significant link between one 2009 H1N1 vaccine and narcolepsy in adults, a finding that is likely to prompt some countries to take a fresh look to see if adult cases have surfaced in the wake of pandemic vaccine campaigns.

Jan 18, 2011

Jan 18, 2011

Northern Hemisphere countries show steady rise in flu

(CIDRAP News) – Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.

Jan 08, 2010

Jan 08, 2010

WHO: Some regions still battle intense flu activity

(CIDRAP News) – Though pandemic flu activity continues to fall across much of the Northern Hemisphere, some parts of the world are hot spots for the virus, including parts of Europe, North Africa, and South Asia, the World Health Organization (WHO) reported today.

Dec 03, 2009

Dec 03, 2009

WHO: It's too early to say pandemic has peaked

(CIDRAP News) – The World Health Organization's (WHO's) top influenza expert said today it's too soon to judge whether the H1N1 influenza pandemic has passed its peak, though he acknowledged that cases are dropping in the United States and Canada.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»